Industry Case Studies: Applied R&D Tax Law in Norwalk

The economic landscape of Norwalk, Connecticut, presents a compelling intersection of historical industrial infrastructure and modern technological innovation. Situated strategically on Long Island Sound, Norwalk was first settled in the 1640s and endured significant destruction during the Revolutionary War. Following the war, the city rebuilt its economy around coastal trade, shipbuilding, and agriculture, eventually evolving into a 19th-century manufacturing powerhouse known for clocks, pottery, hats, and hardware. Today, boasting a population exceeding 91,000 and a highly educated workforce where 45% hold a bachelor’s degree or higher, the city has transitioned from heavy industrial manufacturing to a “creative economy” characterized by software development, green engineering, biomedical research, and advanced boutique manufacturing. The following five case studies illustrate why these specific industries developed in Norwalk and how they navigate the complex United States and Connecticut R&D tax credit laws.

Information Technology and Cybersecurity Software (Datto, Inc.)

The proliferation of information technology (IT) and cybersecurity firms in Norwalk is driven by the city’s geographical and infrastructural advantages. Norwalk is situated along the heavily networked I-95 corridor, providing immediate proximity to the financial hubs of New York City and the academic centers of New England. The municipality’s investment in a robust, reliable fiber-optic network, combined with state-level economic development loans from entities like Connecticut Innovations, created an environment where software-as-a-service (SaaS) companies could scale rapidly without the prohibitive operational costs of Silicon Valley. This ecosystem incubated Datto, Inc., which was founded in 2007 in a Connecticut basement using a rudimentary Lego brick prototype. Datto evolved into a premier provider of backup, disaster recovery, and business continuity (BCDR) solutions, validating its technology during Hurricane Sandy in 2012 by ensuring managed service provider (MSP) customer data remained protected during massive regional power failures. The company grew exponentially, acquiring Backupify in 2014, and was eventually acquired by Vista Equity Partners and later Kaseya.

The development of advanced cybersecurity software and automated BCDR algorithms presents classic qualified research expenses (QREs) under the United States Internal Revenue Code (IRC) Section 41. Software development is subject to intense scrutiny by the Internal Revenue Service (IRS), particularly concerning the distinction between internal-use software (IUS) and software developed for commercial sale, lease, or license. Because a SaaS BCDR platform is deployed externally to MSPs, it is generally exempt from the higher “high threshold of innovation” test applied strictly to IUS.

To satisfy the federal four-part test, the development of a product like the SIRIS 3 all-flash BCDR appliance or a new ransomware detection protocol must demonstrate a permitted purpose, specifically improving the performance and reliability of the software suite. The underlying architecture fundamentally relies on computer science and advanced cryptography, satisfying the technological in nature requirement. At the project’s inception, software engineers face inherent technological uncertainty regarding whether an algorithm can accurately detect an encrypting ransomware payload in real-time without generating false positives that would inadvertently halt legitimate business operations. The engineers engage in a process of experimentation through iterative coding, compiling, load testing, and simulated cyber-attack failovers. Failures and subsequent code revisions during beta testing constitute empirical evidence of this experimental process.

For eligibility under Connecticut law, the statutory framework requires that the research be physically “conducted in Connecticut”. By maintaining its headquarters and technical support personnel in locations like Norwalk (and subsequently expanding within the broader region, including START-UP NY adjacent facilities in Rochester), the firm can aggregate the wages of backend developers, quality assurance automation engineers, and cloud architects. These aggregated wages are eligible for the 20% incremental credit under Connecticut General Statutes (CGS) § 12-217j or the non-incremental sliding scale under CGS § 12-217n, provided the activities meet the federal definitions without running afoul of state-specific geographical exclusions.

Industrial Internet of Things and Advanced Wearables (Triax Technologies)

The transition from 19th-century heavy metalworking to 21st-century advanced manufacturing is epitomized by the Industrial Internet of Things (IIoT). Triax Technologies, headquartered in Norwalk, develops connected wearable devices and 900 MHz mesh networks designed to optimize worksite safety and efficiency. This specific industry developed in Norwalk because the city’s historical blue-collar legacy left a deep regional understanding of physical industrial challenges, while the modern influx of technological talent provided the software engineering required for IoT ecosystems. The blending of physical hardware design with cloud-based analytics represents a specialized “boutique manufacturing” sub-sector that Norwalk’s Urban Core redevelopment agency actively courts to occupy repurposed industrial spaces. Triax initially developed the SIM-P and SIM-G impact monitors to measure head impacts in sports—partnering with athletes like Abby Wambach—before pivoting to construction and hazardous industrial environments with their Spot-r technology, culminating in their 2024 acquisition by Invixium.

The integration of physical hardware prototyping and proprietary cloud software creates a dual-track opportunity for R&D tax credits under both United States and Connecticut law. The hardware development track involves designing Intrinsically Safe (IS) devices, which are wearables meticulously engineered to limit electrical and thermal energy, thereby preventing the ignition of flammable gases or particulates in hazardous environments such as oil refineries and chemical plants. This satisfies the technological in nature test through the application of electrical engineering and applied physics. The process of experimentation involves fabricating prototype printed circuit boards, testing battery thermal limits under extreme stress conditions, and evaluating alternative casing materials. If a prototype fails a rigorous spark-ignition test, the design must be iterated. The costs of the raw materials used to build these specific, non-commercialized prototypes are eligible as supply QREs under IRC § 41(b)(2)(C) and CGS § 12-217n. As established in the seminal United States Tax Court case Union Carbide Corp. v. Commissioner, these supplies must be consumed within the direct process of experimentation, distinguishing them from routine production supplies which are strictly excluded.

The software and networking track involves establishing a reliable, standalone 900 MHz network that operates independently of GPS—capable of transmitting data through the subterranean levels of construction sites or the dense steel infrastructure of refineries. Achieving this involves significant algorithmic uncertainty. Under federal jurisprudence, specifically Eustace v. Commissioner, taxpayers cannot rely on mere estimations or the Cohan doctrine to substantiate QREs. An IoT manufacturer operating in Norwalk must maintain contemporaneous documentation, including computer-aided design (CAD) drawings of the wearable devices, git commit logs for the network firmware, and physical testing laboratory results, to defend the claim during an examination by the IRS or the Connecticut Department of Revenue Services (DRS).

Sustainable Materials and Green Building Technologies (HMTX Industries)

Norwalk’s modern creative economy is heavily supported by architecture, art, and design. This cultural environment, combined with a municipal regulatory commitment to green energy and sustainable infrastructure, attracted the world headquarters of HMTX Industries, a global manufacturer of luxury vinyl tile (LVT) and sustainable flooring. The city’s willingness to support groundbreaking commercial architecture is evidenced by its approval of HMTX’s “House Up On The Hill.” This 24,000-square-foot facility is on track to become the first Living Building Challenge Petal Certified project in Connecticut, designed to operate with zero carbon emissions and generate more renewable energy on-site than it consumes. This demonstrates a powerful symbiotic relationship between municipal zoning flexibility and corporate environmental, social, and governance (ESG) objectives.

The development of sustainable construction materials is fundamentally an exercise in materials science and chemical engineering, qualifying directly for federal and state R&D incentives. A prime example of this qualified research is HMTX’s initiative to create SRP rigid core flooring, an alchemy of responsible beauty that upcycles waste polyethylene terephthalate (PET) plastic bottles into an engineered thermoplastic polyurethane (TPU) core. Transforming post-consumer PET into a structurally sound flooring plank that matches the durability, flexibility, and acoustic properties of virgin materials presents profound chemical and physical uncertainty.

To eliminate this uncertainty, engineers and materials scientists must determine the correct cross-linking methodology to bind the cross-linked polyurethane top layer, the TPU core, and the foam back layer. The process of experimentation involves formulating various chemical ratios, subjecting the extruded prototypes to extreme temperature variations, conducting abrasion testing on the surface, and evaluating the delamination thresholds under heavy load. Under the federal tax code, the salaries of the chemical engineers, industrial designers, and sustainability researchers conducting these experiments in the Norwalk headquarters are qualifying wages. Under CGS § 12-217n, because these wages are paid for research physically conducted within the State of Connecticut, they feed directly into the state credit calculation. Furthermore, if the firm contracts with third-party testing laboratories in the United States to conduct independent stress tests on the new TPU polymers, 65% of those contract costs are eligible QREs, provided the firm retains the substantial rights to the resulting intellectual property and bears the economic risk of the testing outcome, in accordance with the precedent set by Lockheed Martin Corp. v. United States.

Food Technology and Nutritional Science (Get Joy)

The food and beverage manufacturing sector is classified as a targeted “light manufacturing” industry within Norwalk’s urban development plan, specifically concentrated in the South Norwalk (SoNo) district. Get Joy, a canine wellness and food technology company, emerged in Norwalk from a convergence of distinct economic factors: the availability of boutique industrial spaces suitable for specialized food processing, access to a high-income demographic where 52% of the population earns over $100,000 annually and is willing to invest heavily in pet wellness, and proximity to regional agricultural and distribution networks. Founded by Tom Arrix after navigating his own dog’s complex oncology issues, the company utilizes veterinary scientists to develop freeze-dried raw meals, superfood treats, and gut-biome-optimizing supplements. The company has expanded its omnichannel strategy through partnerships with Phillips Pet Food and has even ventured into digital community building with a Metaverse dog park.

While traditional food production is routinely excluded from R&D tax credits, the development of functional, science-backed nutritional products involves complex biological sciences. The research relies on veterinary medicine, cellular biology, and animal nutrition to develop proprietary formulations (such as Belly Biotics) that actively repair the canine gut microbiome using targeted prebiotics, probiotics, and postbiotics. This scientific foundation satisfies the technological in nature requirement. The process of experimentation is evident in the development of the company’s freeze-drying methodology. Developing a lyophilization process that successfully locks in 97% of the nutritional value of raw ingredients while simultaneously achieving shelf stability and preventing the growth of pathogens requires rigorous, iterative scientific testing. Researchers must evaluate different pressure and temperature curves within the lyophilization equipment, testing hypothesis models until the desired moisture content and nutritional density are achieved without compromising cellular structure.

A profound opportunity exists for specialized food-technology companies under Connecticut law. CGS § 12-217j broadly defines a “biotechnology company” as an enterprise engaged in the business of applying technologies such as biochemistry, molecular and cellular biology, or biological cell fusion techniques to modify products or to “improve plants or animals”. Because an enterprise like Get Joy utilizes veterinary nutritionists and biological sciences to develop formulations explicitly intended to improve animal health through gut biome repair and immune support, a compelling legal argument can be constructed that they qualify statutorily as a biotechnology company. If they meet the Qualified Small Business (QSB) revenue thresholds and operate at a current-year tax loss, they could leverage the recent enhancements under Public Act 25-168 to exchange their unutilized Connecticut R&D credits for a 90% cash refund, rather than the standard 65% rate applied to non-biotech entities. This highlights the critical importance of nuanced statutory interpretation in maximizing state-level capital preservation.

Advanced Precision Manufacturing (Aerospace and Medical Components)

The legacy of the 1856 Norwalk Lock Company established an indelible blueprint for metallurgy, tool-and-die making, and hardware fabrication in the region. Utilizing the emerging technology of coal power and taking advantage of convenient rail and water transportation, early industrialists manufactured complex locks, keys, and mechanical devices. Over the ensuing decades, as macroeconomic shifts and low-cost offshore manufacturing decimated traditional American heavy foundries, the surviving manufacturing base in Connecticut evolved into highly specialized, precision-driven operations. Today, the broader regional corridor, with Norwalk serving as a central hub alongside Stamford and Bridgeport, is a vital node in the supply chain for massive aerospace and defense contractors such as Sikorsky Aircraft and Raytheon Technologies, as well as the advanced medical device sector. Norwalk’s highly educated workforce and remaining industrial zoning specifically accommodate computer numerical control (CNC) machining, 3D metal printing, and advanced fabrication facilities.

Precision contract manufacturing is one of the most heavily audited areas for the federal R&D tax credit due to the complexities of the “funded research” exception. When a Norwalk-based precision manufacturer is contracted by an aerospace firm to produce a first-of-its-kind titanium or specialized alloy subcomponent, they must often engineer an entirely new manufacturing process. Even if the aerospace client provides the final CAD drawing of the component, the contract manufacturer faces profound uncertainty regarding the physical methodology of fabrication. The process of designing the custom tooling, programming the multi-axis CNC machines to prevent tool chatter or thermal warping of the aerospace-grade titanium, and developing custom workholding fixtures qualifies as process research under IRC § 41(d).

However, eligibility hinges entirely on the specific terms of the commercial contract. As outlined in the landmark appellate decision Fairchild Industries, Inc. v. United States and reaffirmed in the recent United States Tax Court decision Phoenix Design Group, Inc. v. Commissioner, the manufacturer must retain substantial rights to the manufacturing processes they develop, and the contract must inherently impose the economic risk of failure on the taxpayer. If the contract is structured as a firm-fixed-price agreement, the manufacturer bears the economic risk of scrapped materials, blown deadlines, and iterative process failures, and thus may claim the credit. Conversely, if the contract pays the manufacturer on an hourly “time and materials” basis regardless of the success of the outcome, the IRS will deem the research “funded” and deny the credit to the manufacturer, allocating it instead to the aerospace client.

For Connecticut state credit purposes, the salaries of the manufacturing engineers and floor machinists who are directly involved in running the experimental test-runs on the CNC equipment are eligible QREs, provided the physical machining occurs in the Norwalk facility. The specialized metals and tooling materials scrapped during these failed test runs are also eligible as supply QREs under CGS § 12-217n, yielding significant reductions in corporate business tax liabilities.

Detailed Analysis of United States Federal R&D Tax Credit Laws

The federal Credit for Increasing Research Activities was originally enacted by the United States Congress in 1981. Driven by concerns that private sector spending on research and experimentation was declining, lawmakers designed the credit to incentivize domestic capital investment, foster long-term innovation, and maintain the nation’s competitive technological edge in the global macroeconomic landscape. Codified primarily under Internal Revenue Code (IRC) Section 41, the credit provides a direct, dollar-for-dollar reduction in a corporate taxpayer’s federal income tax liability. The credit is generally calculated as a percentage of qualified research expenses (QREs) that exceed a statutorily defined historical base amount. Concurrently, IRC Section 174 governs the treatment of these same research and experimental expenditures for standard deduction and amortization purposes.

The Strict Four-Part Test for Qualified Research

The threshold for claiming the federal R&D tax credit is notably rigorous. The IRS mandates that for any activity to be considered “qualified research,” the taxpayer must unequivocally establish that the activity meets a strict four-part test, as defined in IRC Section 41(d). Crucially, these tests must be applied separately to each specific business component (defined as a product, process, computer software, technique, formula, or invention) rather than to the business operations as an aggregate whole.

Qualified Research Expenses (QREs)

Under the definitions provided in IRC Section 41(b)(1), QREs are strictly limited to the sum of in-house research expenses and contract research expenses. Overhead, general administrative costs, and capital expenditures (such as purchasing manufacturing equipment or real estate) are excluded.

The allowable expenses are categorized as follows:

• Wages: Amounts paid to employees for directly performing, directly supervising, or directly supporting qualified research activities. For example, the wages of an engineer writing code, the direct manager reviewing the code, and the laboratory technician setting up the testing server all qualify.
• Supplies: Tangible property used or consumed in the direct conduct of qualified research. Utilities (electricity, water) and telecommunications are generally excluded unless they are demonstrably extraordinary and directly tied to the experimental process.
• Contract Research: Generally, 65% of the amounts paid or incurred by the taxpayer to an unrelated third party for performing qualified research on the taxpayer’s behalf. If the payments are made to a qualified research consortium (such as a 501(c)(3) scientific research organization), the inclusion rate is elevated to 75% under IRC Section 41(b)(3)(C).

Jurisprudence: Shaping the Boundaries of Eligibility

Federal case law serves as the primary mechanism for interpreting the broadly written statutes of IRC Section 41. The United States Tax Court and various Circuit Courts of Appeal have established stringent precedents that govern IRS audit examinations.

The definition of a “process of experimentation” was fundamentally narrowed by United Stationers Supply Co. v. United States (2000), where the Fifth Circuit Court of Appeals ruled that the taxpayer must seek to discover information that goes beyond the current state of knowledge in the relevant field, rather than merely applying existing knowledge to a new context. The procedural requirements of experimentation were further refined in Intermountain Electronics, where the IRS successfully argued that the production of pilot models did not meet the “substantially all” (80%) test for R&D activities, reinforcing that production-related expenses often fail to qualify as experimental research.

The substantiation of expenses is governed by the rigid precedent set in Eustace v. Commissioner (2001). The Tax Court, affirmed by the Seventh Circuit, explicitly rejected the use of the Cohan doctrine for R&D tax credits. The Cohan doctrine traditionally allows taxpayers to estimate certain deductible expenses if they can prove the expenses were incurred but lack exact receipts. However, for R&D credits, Eustace mandates that taxpayers must provide strict, contemporaneous documentation connecting specific employee hours and specific supply costs to particular technological uncertainties and experimental processes. The failure to maintain adequate documentation not only results in the disallowance of the credit but can trigger gross overstatement penalties, as upheld in United States v. McFerrin (2009).

The treatment of supplies consumed during the research process was clarified in Union Carbide Corp. v. Commissioner (2009). The Second Circuit Court of Appeals affirmed the disallowance of supply costs incurred during routine process testing, emphasizing that the “experimentation” prong requires supplies to be consumed in a genuine attempt to resolve technical uncertainty, not merely as a byproduct of validating a process that is already operational for commercial production.

Perhaps the most heavily litigated area is the “funded research” exclusion under IRC Section 41(d)(4)(H). The landmark case Fairchild Industries, Inc. v. United States (1995) established that payments from a third party disqualify a taxpayer from claiming the credit if the taxpayer bears no economic risk of failure. This was later expanded by Lockheed Martin Corp. v. United States (2000), which determined that a taxpayer must also retain “substantial rights” to the results of the research to claim the credit, even in the context of highly restrictive government defense contracts. The principles of Fairchild and Lockheed continue to dictate modern outcomes, as seen in the recent Phoenix Design Group and Smith cases, where the Tax Court meticulously analyzed the indemnity clauses, milestone payment structures, and intellectual property retention rights within architectural and engineering service contracts to determine economic risk.

Evolving Compliance and Legislative Horizons

The regulatory environment for the federal R&D tax credit is currently undergoing massive structural changes. The IRS has significantly increased its scrutiny of R&D claims, transitioning to a regime requiring extensive, upfront substantiation. This is most evident in the comprehensive revisions to IRS Form 6765 (Credit for Increasing Research Activities). Expected to become mandatory for tax year 2025 (after being delayed from 2024), the revised form includes entirely new sections that require taxpayers to provide highly detailed, project-by-project qualitative information, essentially mandating that audit defense documentation be submitted at the time of the original tax filing. Section G of the new form will demand specific disclosures regarding the type of software developed and the exact nature of the uncertainties faced.

Concurrently, the treatment of domestic R&D expenditures is subject to pending legislative relief. Under the provisions of the Tax Cuts and Jobs Act (TCJA) that took effect in 2022, taxpayers were required to capitalize and amortize domestic Section 174 research expenses over 5 years (and 15 years for foreign research), eliminating the ability to immediately deduct these costs in the year incurred. However, the proposed “One Big Beautiful Bill Act” (advanced in 2024 and 2025) seeks to retroactively restore immediate expensing for domestic R&D costs for tax years beginning after December 31, 2024. If enacted, this legislation will allow corporate taxpayers to either fully deduct their remaining unamortized domestic R&D expenses from 2022-2024 in the 2025 tax year, or spread the deduction evenly over 2025 and 2026, while foreign research costs will remain subject to the 15-year amortization schedule to aggressively encourage the reshoring of technical jobs to locations like Norwalk.

Detailed Analysis of Connecticut State R&D Tax Credit Laws

The State of Connecticut operates a bifurcated, aggressive, and highly lucrative R&D tax credit system administered by the Connecticut Department of Revenue Services (DRS). Enacted under Connecticut General Statutes (CGS) §§ 12-217j and 12-217n, these credits are applied against the Corporation Business Tax. The state statutes deliberately mirror the federal definitions of qualified research under IRC Section 41 and research and experimental expenditures under Section 174, but append critical geographical constraints and offer unique monetization pathways for pre-revenue enterprises.

The Bifurcated Credit System: Incremental vs. Non-Incremental

Connecticut offers two distinct R&D credits. A fundamental rule of state tax administration is the prohibition against “double-dipping”; a taxpayer cannot claim both the incremental and non-incremental credit on the exact same pool of qualified expenditures in a single income year, requiring an annual strategic election based on expenditure growth rates.

The “Conducted in Connecticut” Geographical Mandate

To qualify for either Connecticut credit, the expenditures must meet stringent state-level criteria managed actively by the DRS. The primary differentiator from the federal code is the geographical nexus requirement: the expenditures or payments must be paid or incurred for research and development and basic research that is strictly “conducted in Connecticut”.

If an aerospace contractor maintains its corporate headquarters in Norwalk, Connecticut, but outsources its metallurgical testing to a laboratory in Texas and houses its software development team in India, only the wages and supplies consumed by the personnel physically operating within the borders of Connecticut are eligible for the CGS §§ 12-217j and 12-217n credits. Furthermore, the DRS enforces strict exclusions. According to DRS Policy Statement 2004(2.1), overhead expenses, general and administrative costs, the ordinary testing or inspection of materials for quality control, consumer surveys, advertising, and management studies are explicitly excluded from the definition of state QREs. The DRS also mirrors the federal IRC § 41(d)(4)(H) exclusion, demanding that the research must not be funded by any grant or contract with a public or private entity.

The Qualified Small Business Refund Exchange Mechanism

Perhaps the most economically impactful feature of the Connecticut tax code for startups operating in Norwalk is the Exchange of Tax Credit mechanism. Recognizing that pre-revenue technology and life science companies incur massive R&D costs but generate zero taxable income—rendering non-refundable tax credits immediately useless—the state legislature created a monetization pathway.

A Qualified Small Business (QSB)—defined by the DRS as a company that has a gross income for the previous income year that does not exceed $70 million and has no tax liability (or a capital base tax equal to $250)—may elect to exchange its unutilized Connecticut R&D credits with the state for a direct cash refund.

For a standard QSB (such as a software developer or IoT manufacturer), the state will refund an amount equal to 65% of the credit’s value, subject to an absolute maximum annual refund cap of $1.5 million per company. The remaining 35% of the credit’s value is forfeited in the exchange.

The Biotechnology Enhancement (PA 25-168): In a massive legislative effort to anchor the biomedical and life sciences industry within the state, the Connecticut legislature enacted Public Act 25-168 (H.B. 7287), applicable to income years commencing on or after January 1, 2025. This legislation elevated the cash refund exchange rate from 65% to an unprecedented 90% specifically for “qualifying small biotechnology companies”. The statutory definition of a biotechnology company is broad, encompassing firms applying recombinant DNA techniques, biochemistry, molecular biology, genetics, and bioprocesses to produce or modify products, identify pharmaceutical targets, or transform biological systems. This 90% exchange rate provides massive liquidity to clinical-stage pharmaceutical firms and specialized food-technology developers operating in Norwalk, drastically reducing their cash-burn rates and reliance on venture capital during prolonged periods of scientific experimentation.

Utilization Limits and Judicial Interpretation

For profitable corporations that do not qualify for the QSB cash exchange, the utilization of the R&D tax credit against the Corporation Business Tax is subject to strict statutory ceilings. Historically capped at 50.01%, the utilization limit was expanded to allow credits to offset up to 60% of the tax due in income year 2022, and currently allows the offsetting of up to 70% of the tax due for income year 2023 and all subsequent years. The DRS also mandates a strict ordering rule: all allowable tax credits carried forward from prior years must be fully applied before any current year tax credit may be taken, preventing the strategic expiration of older credit tranches.

The interpretation of these statutes is overseen by the Supreme Court of Connecticut, which historically applies a doctrine of strict construction to tax exemptions and credits, resolving ambiguities in favor of the taxing authority. The burden of proof rests entirely on the taxpayer to demonstrate unambiguous eligibility under the specific language of CGS §§ 12-217j or 12-217n. The state’s administrative appeal process allows corporations to file a protest of a determination of tax, but the foundational requirement of contemporaneous documentation regarding the physical location and experimental nature of the research remains the paramount defensive strategy in any DRS examination.

Final Thoughts

The intersection of the United States federal tax code and the Connecticut General Statutes provides a highly lucrative, yet immensely complex, financial incentive architecture for businesses driving technological innovation. As demonstrated through the historical and economic evolution of Norwalk—from the 19th-century foundries of the Norwalk Lock Company to the modern, Living Building Certified headquarters of advanced material science firms—the physical geography of industry inherently dictates the application of tax law.

Whether it is a cybersecurity software firm optimizing cloud architecture, a food technology startup applying cellular biology to veterinary nutrition, or a precision manufacturer designing tooling for aerospace components, the fundamental requirements for the R&D tax credit remain uniform: a permitted purpose, technological reliance on hard science, the elimination of objective uncertainty, and a systematic process of experimentation. By meticulously aligning their internal engineering, development, and accounting workflows with these rigid statutory requirements, and navigating the nuances of the funded research exception and the Connecticut QSB cash refund exchange mechanism, businesses in Norwalk can effectively utilize R&D tax credits to underwrite the immense costs of their future growth. The transition to the enhanced 90% refund rate for Connecticut biotechnology firms further cements the state’s aggressive intent to remain a vital, highly competitive node in the national innovation economy.

The information in this study is current as of the date of publication, and is provided for information purposes only. Although we do our absolute best in our attempts to avoid errors, we cannot guarantee that errors are not present in this study. Please contact a Swanson Reed member of staff, or seek independent legal advice to further understand how this information applies to your circumstances.